NR2F6 expression level was also found to be higher in long-acting hematopoietic stem cells than in short-acting hematopoietic stem cells and progenitor cells, and its expression level was low in induced differentiated AML cells. The gene discussed is NR2F6; the disease is acute myeloid leukemia.